| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |